Molecular basis for multimerization in the activation of the epidermal growth factor receptor

eLife

Volumn 5, Issue MARCH2016, 2016, Pages

  Huang, Yongjian ^a,b   Bharill, Shashank ^a   Karandur, Deepti ^a,b   Peterson, Sean M ^a,b   Marita, Morgan ^c   Shi, Xiaojun ^c   Kaliszewski, Megan J ^c   Smith, Adam W ^c   Isacoff, Ehud Y ^a,b,d   Kuriyan, John ^a,b,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF AKRON   (United States)

^d LAWRENCE BERKELEY NATIONAL LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; PHOSPHATIDYLINOSITOL 3 KINASE; EGFR PROTEIN, HUMAN; MUTANT PROTEIN;

ALLOSTERISM; ANIMAL TISSUE; ARTICLE; BINDING SITE; CONTROLLED STUDY; DIMERIZATION; ENZYME ACTIVE SITE; ENZYME ACTIVITY; FLOW CYTOMETRY; FLUORESCENCE CORRELATION SPECTROSCOPY; FLUORESCENCE MICROSCOPY; HUMAN; LIGAND BINDING; MOLECULAR DOCKING; NONHUMAN; PROTEIN EXPRESSION; PROTEIN MULTIMERIZATION; PROTEIN PHOSPHORYLATION; STOICHIOMETRY; XENOPUS; ANIMAL; DNA MUTATIONAL ANALYSIS; GENETICS; METABOLISM; OOCYTE; PHOSPHORYLATION; PROTEIN PROCESSING; SINGLE MOLECULE IMAGING;

ALLOSTERIC REGULATION; ANIMALS; DNA MUTATIONAL ANALYSIS; MUTANT PROTEINS; OOCYTES; PHOSPHATIDYLINOSITOL 3-KINASE; PHOSPHORYLATION; PROTEIN MULTIMERIZATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; RECEPTOR, EPIDERMAL GROWTH FACTOR; SINGLE MOLECULE IMAGING; XENOPUS;

EID: 84979536687     PISSN: None     EISSN: 2050084X     Source Type: Journal    
DOI: 10.7554/eLife.14107     Document Type: Article

References (81)

1. Aertgeerts K, Skene R, Yano J, Sang BC, Zou H, Snell G, Jennings A, Iwamoto K, Habuka N, Hirokawa A, Ishikawa T, Tanaka T, Miki H, Ohta Y, Sogabe S. 2011. Structural analysis of the mechanism of inhibition and allosteric activation of the kinase domain of HER2 protein. The Journal of Biological Chemistry 286: 18756-18765. doi: 10.1074/jbc.M110.206193
2. Alvarado D, Klein DE, Lemmon MA. 2010. Structural basis for negative cooperativity in growth factor binding to an EGF receptor. Cell 142: 568-579. doi: 10.1016/j.cell.2010.07.015
3. Arkhipov A, Shan Y, Das R, Endres NF, Eastwood MP, Wemmer DE, Kuriyan J, Shaw DE. 2013a. Architecture and Membrane Interactions of the EGF Receptor. Cell 152: 557-569. doi: 10.1016/j.cell.2012.12.030
4. Arkhipov A, Shan Y, Kim ET, Dror RO, Shaw DE. 2013b. Her2 activation mechanism reflects evolutionary preservation of asymmetric ectodomain dimers in the human EGFR family. eLife 2: e00708. doi: 10.7554/eLife.00708
5. Batzer AG, Rotin D, Ureña JM, Skolnik EY, Schlessinger J. 1994. Hierarchy of binding sites for Grb2 and Shc on the epidermal growth factor receptor. Molecular and Cellular Biology 14: 5192-5201. doi: 10.1128/MCB.14.8.5192
6. DeFrees DJ, McLean AD. 1984. Basis set limit geometries for ammonia at the SCF and MP2 levels of theory. The Journal of Chemical Physics 81. doi: 10.1063/1.448003
7. Bussi G, Donadio D, Parrinello M. 2007. Canonical sampling through velocity rescaling. The Journal of Chemical Physics 126. doi: 10.1063/1.2408420
8. Case DA, Cheatham TE, Darden T, Gohlke H, Luo R, Merz KM, Onufriev A, Simmerling C, Wang B, Woods RJ. 2005. The Amber biomolecular simulation programs. Journal of Computational Chemistry 26: 1668-1688. doi: 10.1002/jcc.20290
9. Chen Y, Bharill S, Isacoff EY, Chalfie M. 2015. Subunit composition of a DEG/ENaC mechanosensory channel of Caenorhabditis elegans. Proceedings of the National Academy of Sciences of the United States of America 112: 11690-11695. doi: 10.1073/pnas.1515968112
10. Chung I, Akita R, Vandlen R, Toomre D, Schlessinger J, Mellman I. 2010. Spatial control of EGF receptor activation by reversible dimerization on living cells. Nature 464: 783-787. doi: 10.1038/nature08827
11. Citri A, Skaria KB, Yarden Y. 2003. The deaf and the dumb: the biology of ErbB-2 and ErbB-3. Experimental Cell Research 284: 54-65. doi: 10.1016/S0014-4827(02)00101-5
12. Clayton AH, Walker F, Orchard SG, Henderson C, Fuchs D, Rothacker J, Nice EC, Burgess AW. 2005. Ligand-induced dimer-tetramer transition during the activation of the cell surface epidermal growth factor receptor-a multidimensional microscopy analysis. The Journal of Biological Chemistry 280: 30392-30399. doi: 10.1074/jbc.M504770200
13. Clayton AH, Orchard SG, Nice EC, Posner RG, Burgess AW. 2008. Predominance of activated EGFR higher-order oligomers on the cell surface. Growth Factors 26: 316-324. doi: 10.1080/08977190802442187
14. Comar WD, Schubert SM, Jastrzebska B, Palczewski K, Smith AW. 2014. Time-resolved fluorescence spectroscopy measures clustering and mobility of a G protein-coupled receptor opsin in live cell membranes. Journal of the American Chemical Society 136. doi: 10.1021/ja501948w
15. Dawson JP, Berger MB, Lin CC, Schlessinger J, Lemmon MA, Ferguson KM. 2005. Epidermal growth factor receptor dimerization and activation require ligand-induced conformational changes in the dimer interface. Molecular and Cellular Biology 25: 7734-7742. doi: 10.1128/MCB.25.17.7734-7742.2005
16. Dawson JP, Bu Z, Lemmon MA. 2007. Ligand-induced structural transitions in ErbB receptor extracellular domains. Structure 15: 942-954. doi: 10.1016/j.str.2007.06.013
17. Digman MA, Gratton E. 2009. Fluorescence correlation spectroscopy and fluorescence cross-correlation spectroscopy. Wiley Interdisciplinary Reviews. Systems Biology and Medicine 1: 273-282. doi: 10.1002/wsbm.5
18. Endres NF, Das R, Smith AW, Arkhipov A, Kovacs E, Huang Y, Pelton JG, Shan Y, Shaw DE, Wemmer DE, Groves JT, Kuriyan J. 2013. Conformational coupling across the plasma membrane in activation of the EGF receptor. Cell 152: 543-556. doi: 10.1016/j.cell.2012.12.032
19. Endres NF, Barros T, Cantor AJ, Kuriyan J. 2014. Emerging concepts in the regulation of the EGF receptor and other receptor tyrosine kinases. Trends in Biochemical Sciences 39: 437-446. doi: 10.1016/j.tibs.2014.08.001
20. Ferguson KM, Berger MB, Mendrola JM, Cho HS, Leahy DJ, Lemmon MA. 2003. EGF activates its receptor by removing interactions that autoinhibit ectodomain dimerization. Molecular Cell 11: 507-517. doi: 10.1016/S1097-2765(03)00047-9
21. Fleishman SJ, Schlessinger J, Ben-Tal N. 2002. A putative molecular-activation switch in the transmembrane domain of erbB2. Proceedings of the National Academy of Sciences of the United States of America 99: 15937-15940. doi: 10.1073/pnas.252640799
22. Garrett TP, McKern NM, Lou M, Elleman TC, Adams TE, Lovrecz GO, Zhu HJ, Walker F, Frenkel MJ, Hoyne PA, Jorissen RN, Nice EC, Burgess AW, Ward CW. 2002. Crystal structure of a truncated epidermal growth factor receptor extracellular domain bound to transforming growth factor alpha. Cell 110: 763-773. doi: 10.1016/S0092-8674(02)00940-6
23. Gong Y, Renigunta V, Zhou Y, Sunq A, Wang J, Yang J, Renigunta A, Baker LA, Hou J. 2015. Biochemical and biophysical analyses of tight junction permeability made of claudin-16 and claudin-19 dimerization. Molecular Biology of the Cell 26: 4333-4346. doi: 10.1091/mbc.E15-06-0422
24. Heinzmann U, Höfler H. 1994. Detection of epidermal growth factor receptor by scanning electron microscopy. Histochemistry 101: 127-134. doi: 10.1007/BF00269359
25. Jones JT, Akita RW, Sliwkowski MX. 1999. Binding specificities and affinities of egf domains for ErbB receptors. FEBS Letters 447: 227-231. doi: 10.1016/S0014-5793(99)00283-5
26. Jones RB, Gordus A, Krall JA, MacBeath G. 2006. A quantitative protein interaction network for the ErbB receptors using protein microarrays. Nature 439: 168-174. doi: 10.1038/nature04177
27. Jura N, Endres NF, Engel K, Deindl S, Das R, Lamers MH, Wemmer DE, Zhang X, Kuriyan J. 2009a. Mechanism for activation of the EGF receptor catalytic domain by the juxtamembrane segment. Cell 137: 1293-1307. doi: 10.1016/j.cell.2009.04.025
28. Jura N, Shan Y, Cao X, Shaw DE, Kuriyan J. 2009a. Structural analysis of the catalytically inactive kinase domain of the human EGF receptor 3. Proceedings of the National Academy of Sciences of the United States of America 106: 21608-21613. doi: 10.1073/pnas.0912101106
29. Jura N, Zhang X, Endres NF, Seeliger MA, Schindler T, Kuriyan J. 2011. Catalytic control in the EGF receptor and its connection to general kinase regulatory mechanisms. Molecular Cell 42: 9-22. doi: 10.1016/j.molcel.2011.03.004
30. Koland JG. 2014. Coarse-grained molecular simulation of epidermal growth factor receptor protein tyrosine kinase multi-site self-phosphorylation. PLoS Computational Biology 10: e1003435. doi: 10.1371/journal.pcbi.1003435
31. Korennykh AV, Egea PF, Korostelev AA, Finer-Moore J, Zhang C, Shokat KM, Stroud RM, Walter P. 2009. The unfolded protein response signals through high-order assembly of Ire1. Nature 457: 687-693. doi: 10.1038/nature07661
32. Kovacs E, Zorn JA, Huang Y, Barros T, Kuriyan J. 2015a. A structural perspective on the regulation of the epidermal growth factor receptor. Annual Review of Biochemistry 84: 739-764. doi: 10.1146/annurev-biochem-060614-034402
33. Kovacs E, Das R, Wang Q, Collier TS, Cantor A, Huang Y, Wong K, Mirza A, Barros T, Grob P, Jura N, Bose R, Kuriyan J. 2015b. Analysis of the role of the C-terminal tail in the regulation of the epidermal growth factor receptor. Molecular and Cellular Biology 35: 3083-3102. doi: 10.1128/MCB.00248-15
34. Kozakov D, Beglov D, Bohnuud T, Mottarella SE, Xia B, Hall DR, Vajda S. 2013. How good is automated protein docking?. Proteins: Structure, Function, and Bioinformatics 81: 2159-2166. doi: 10.1002/prot.24403
35. Kozer N, Barua D, Orchard S, Nice EC, Burgess AW, Hlavacek WS, Clayton AH. 2013. Exploring higher-order EGFR oligomerisation and phosphorylation-a combined experimental and theoretical approach. Molecular bioSystems 9: 1849-1863. doi: 10.1039/c3mb70073a
36. Kozer N, Barua D, Henderson C, Nice EC, Burgess AW, Hlavacek WS, Clayton AH. 2014. Recruitment of the adaptor protein Grb2 to EGFR tetramers. Biochemistry 53: 2594-2604. doi: 10.1021/bi500182x
37. Leahy DJ. 2004. Structure and function of the epidermal growth factor (EGF/ErbB) family of receptors. Advances in Protein Chemistry 68: 1-27. doi: 10.1016/S0065-3233(04)68001-6
38. Lemmon MA, Bu Z, Ladbury JE, Zhou M, Pinchasi D, Lax I, Engelman DM, Schlessinger J. 1997. Two EGF molecules contribute additively to stabilization of the EGFR dimer. The EMBO Journal 16: 281-294. doi: 10.1093/emboj/16.2.281
39. Lemmon MA, Schlessinger J, Ferguson KM. 2014. The EGFR family: not so prototypical receptor tyrosine kinases. Cold Spring Harbor Perspectives in Biology 6: a020768. doi: 10.1101/cshperspect.a020768
40. Liu P, Cleveland TE, Bouyain S, Byrne PO, Longo PA, Leahy DJ. 2012. A single ligand is sufficient to activate EGFR dimers. Proceedings of the National Academy of Sciences of the United States of America 109: 10861-10866. doi: 10.1073/pnas.1201114109
41. Lu C, Mi LZ, Grey MJ, Zhu J, Graef E, Yokoyama S, Springer TA. 2010. Structural evidence for loose linkage between ligand binding and kinase activation in the epidermal growth factor receptor. Molecular and Cellular Biology 30: 5432-5443. doi: 10.1128/MCB.00742-10
42. Lynch TJ, Bell DW, Sordella R, Gurubhagavatula S, Okimoto RA, Brannigan BW, Harris PL, Haserlat SM, Supko JG, Haluska FG, Louis DN, Christiani DC, Settleman J, Haber DA. 2004. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. The New England Journal of Medicine 350: 2129-2139. doi: 10.1056/NEJMoa040938
43. Margolis BL, Lax I, Kris R, Dombalagian M, Honegger AM, Howk R, Givol D, Ullrich A, Schlessinger J. 1989. All autophosphorylation sites of epidermal growth factor (EGF) receptor and HER2/neu are located in their carboxyl-terminal tails. Identification of a novel site in EGF receptor. The Journal of Biological Chemistry 264: 10667-10671.
44. Marita M, Wang Y, Kaliszewski MJ, Skinner KC, Comar WD, Shi X, Dasari P, Zhang X, Smith AW. 2015. Class a plexins are organized as preformed inactive dimers on the cell surface. Biophysical Journal 109: 1937-1945. doi: 10.1016/j.bpj.2015.04.043
45. Marrink SJ, Risselada HJ, Yefimov S, Tieleman DP, de Vries AH. 2007. The MARTINI force field: coarse grained model for biomolecular simulations. The Journal of Physical Chemistry. B 111: 7812-7824. doi: 10.1021/jp071097f
46. Mendrola JM, Berger MB, King MC, Lemmon MA. 2002. The single transmembrane domains of ErbB receptors self-associate in cell membranes. The Journal of Biological Chemistry 277: 4704-4712. doi: 10.1074/jbc.M108681200
47. Mineev KS, Bocharov EV, Pustovalova YE, Bocharova OV, Chupin VV, Arseniev AS. 2010. Spatial structure of the transmembrane domain heterodimer of ErbB1 and ErbB2 receptor tyrosine kinases. Journal of Molecular Biology 400: 231-243. doi: 10.1016/j.jmb.2010.05.016
48. Monticelli L, Kandasamy SK, Periole X, Larson RG, Tieleman DP, Marrink SJ. 2008. The MARTINI coarse-grained force field: Extension to proteins. Journal of Chemical Theory and Computation 4: 819-834. doi: 10.1021/ct700324x
49. Muthuswamy SK, Gilman M, Brugge JS. 1999. Controlled dimerization of ErbB receptors provides evidence for differential signaling by homo- and heterodimers. Molecular and Cellular Biology 19: 6845-6857. doi: 10.1128/MCB.19.10.6845
50. Müller BK, Zaychikov E, Bräuchle C, Lamb DC. 2005. Pulsed interleaved excitation. Biophysical Journal 89: 3508-3522. doi: 10.1529/biophysj.105.064766
51. Nagy P, Claus J, Jovin TM, Arndt-Jovin DJ. 2010. Distribution of resting and ligand-bound ErbB1 and ErbB2 receptor tyrosine kinases in living cells using number and brightness analysis. Proceedings of the National Academy of Sciences of the United States of America 107: 16524-16529. doi: 10.1073/pnas.1002642107
52. Ogiso H, Ishitani R, Nureki O, Fukai S, Yamanaka M, Kim JH, Saito K, Sakamoto A, Inoue M, Shirouzu M, Yokoyama S. 2002. Crystal structure of the complex of human epidermal growth factor and receptor extracellular domains. Cell 110: 775-787. doi: 10.1016/S0092-8674(02)00963-7
53. Opresko LK, Wiley HS. 1990. Functional reconstitutional of the human epidermal growth factor receptor system in Xenopus oocytes. The Journal of Cell Biology 111: 1661-1671. doi: 10.1083/jcb.111.4.1661
54. Paez JG, Jänne PA, Lee JC, Tracy S, Greulich H, Gabriel S, Herman P, Kaye FJ, Lindeman N, Boggon TJ, Naoki K, Sasaki H, Fujii Y, Eck MJ, Sellers WR, Johnson BE, Meyerson M. 2004. EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy. Science 304: 1497-1500. doi: 10.1126/science.1099314
55. Pao W, Miller V, Zakowski M, Doherty J, Politi K, Sarkaria I, Singh B, Heelan R, Rusch V, Fulton L, Mardis E, Kupfer D, Wilson R, Kris M, Varmus H. 2004. EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib. Proceedings of the National Academy of Sciences of the United States of America 101: 13306-13311. doi: 10.1073/pnas.0405220101
56. Parrinello M. 1981. Polymorphic transitions in single crystals: A new molecular dynamics method. Journal of Applied Physics 52: 7182. doi: 10.1063/1.328693
57. Pike LJ. 2012. Negative co-operativity in the EGF receptor. Biochemical Society Transactions 40: 15-19. doi: 10.1042/BST20110610
58. Pronk S, Páll S, Schulz R, Larsson P, Bjelkmar P, Apostolov R, Shirts MR, Smith JC, Kasson PM, van der Spoel D, Hess B, Lindahl E. 2013. GROMACS 4.5: a high-throughput and highly parallel open source molecular simulation toolkit. Bioinformatics 29: 845-854. doi: 10.1093/bioinformatics/btt055
59. Qiu C, Tarrant MK, Choi SH, Sathyamurthy A, Bose R, Banjade S, Pal A, Bornmann WG, Lemmon MA, Cole PA, Leahy DJ. 2008. Mechanism of activation and inhibition of the HER4/ErbB4 kinase. Structure 16: 460-467. doi: 10.1016/j.str.2007.12.016
60. Red Brewer M, Choi SH, Alvarado D, Moravcevic K, Pozzi A, Lemmon MA, Carpenter G. 2009. The juxtamembrane region of the EGF receptor functions as an activation domain. Molecular Cell 34: 641-651. doi: 10.1016/j.molcel.2009.04.034
61. Red Brewer M, Yun CH, Lai D, Lemmon MA, Eck MJ, Pao W. 2013. Mechanism for activation of mutated epidermal growth factor receptors in lung cancer. Proceedings of the National Academy of Sciences of the United States of America 110: E3595-E3604. doi: 10.1073/pnas.1220050110
62. Ruan Z, Kannan N. 2015. Mechanistic insights into R776H mediated activation of epidermal growth factor receptor kinase. Biochemistry 54: 4216-4225. doi: 10.1021/acs.biochem.5b00444
63. Schlessinger J. 2002. Ligand-induced, receptor-mediated dimerization and activation of EGF receptor. Cell 110: 669-672. doi: 10.1016/S0092-8674(02)00966-2
64. Shan Y, Eastwood MP, Zhang X, Kim ET, Arkhipov A, Dror RO, Jumper J, Kuriyan J, Shaw DE. 2012. Oncogenic mutations counteract intrinsic disorder in the EGFR kinase and promote receptor dimerization. Cell 149: 860-870. doi: 10.1016/j.cell.2012.02.063
65. Shi F, Telesco SE, Liu Y, Radhakrishnan R, Lemmon MA. 2010. ErbB3/HER3 intracellular domain is competent to bind ATP and catalyze autophosphorylation. Proceedings of the National Academy of Sciences of the United States of America 107: 7692-7697. doi: 10.1073/pnas.1002753107
66. Slamon DJ, Leyland-Jones B, Shak S, Fuchs H, Paton V, Bajamonde A, Fleming T, Eiermann W, Wolter J, Pegram M, Baselga J, Norton L. 2001. Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. The New England Journal of Medicine 344: 783-792. doi: 10.1056/NEJM200103153441101
67. Sliwkowski MX, Schaefer G, Akita RW, Lofgren JA, Fitzpatrick VD, Nuijens A, Fendly BM, Cerione RA, Vandlen RL, Carraway KL. 1994. Coexpression of erbB2 and erbB3 proteins reconstitutes a high affinity receptor for heregulin. The Journal of Biological Chemistry 269: 14661-14665.
68. Smith AW. 2015. Detection of rhodopsin dimerization in situ by PIE-FCCS, a time-resolved fluorescence spectroscopy. Methods in Molecular Biology 1271: 205-219. doi: 10.1007/978-1-4939-2330-4_14
69. Sonnleitner A, Mannuzzu LM, Terakawa S, Isacoff EY. 2002. Structural rearrangements in single ion channels detected optically in living cells. Proceedings of the National Academy of Sciences of the United States of America 99: 12759-12764. doi: 10.1073/pnas.192261499
70. Stamos J, Sliwkowski MX, Eigenbrot C. 2002. Structure of the epidermal growth factor receptor kinase domain alone and in complex with a 4-anilinoquinazoline inhibitor. The Journal of Biological Chemistry 277: 46265-46272. doi: 10.1074/jbc.M207135200
71. Ulbrich MH, Isacoff EY. 2007. Subunit counting in membrane-bound proteins. Nature Methods 4: 319-321. doi: 10.1038/nmeth1024
72. Valley CC, Arndt-Jovin DJ, Karedla N, Steinkamp MP, Chizhik AI, Hlavacek WS, Wilson BS, Lidke KA, Lidke DS. 2015. Enhanced dimerization drives ligand-independent activity of mutant epidermal growth factor receptor in lung cancer. Molecular Biology of the Cell 26: 4087-4099. doi: 10.1091/mbc.E15-05-0269
73. Wassenaar TA, Ingólfsson HI, Böckmann RA, Tieleman DP, Marrink SJ. 2015. Computational lipidomics with insane: A versatile tool for generating custom membranes for molecular simulations. Journal of Chemical Theory and Computation 11: 2144-2155. doi: 10.1021/acs.jctc.5b00209
74. Yang TT, Cheng L, Kain SR. 1996. Optimized codon usage and chromophore mutations provide enhanced sensitivity with the green fluorescent protein. Nucleic Acids Research 24: 4592-4593. doi: 10.1093/nar/24.22.4592
75. Yarden Y, Schlessinger J. 1987a. Epidermal growth factor induces rapid, reversible aggregation of the purified epidermal growth factor receptor. Biochemistry 26: 1443-1451. doi: 10.1021/bi00379a035
76. Yarden Y, Schlessinger J. 1987b. Self-phosphorylation of epidermal growth factor receptor: evidence for a model of intermolecular allosteric activation. Biochemistry 26: 1434-1442. doi: 10.1021/bi00379a034
77. Yarden Y, Sliwkowski MX. 2001. Untangling the ErbB signalling network. Nature Reviews. Molecular Cell Biology 2: 127-137. doi: 10.1038/35052073
78. Zhang X, Gureasko J, Shen K, Cole PA, Kuriyan J. 2006. An allosteric mechanism for activation of the kinase domain of epidermal growth factor receptor. Cell 125: 1137-1149. doi: 10.1016/j.cell.2006.05.013
79. Zhang Q, Park E, Kani K, Landgraf R. 2012. Functional isolation of activated and unilaterally phosphorylated heterodimers of ERBB2 and ERBB3 as scaffolds in ligand-dependent signaling. Proceedings of the National Academy of Sciences of the United States of America 109: 13237-13242. doi: 10.1073/pnas.1200105109
80. Zhang F, Wang S, Yin L, Yang Y, Guan Y, Wang W, Xu H, Tao N. 2015. Quantification of epidermal growth factor receptor expression level and binding kinetics on cell surfaces by surface plasmon resonance imaging. Analytical Chemistry 87: 9960-9965. doi: 10.1021/acs.analchem.5b02572
81. Zhen Y, Caprioli RM, Staros JV. 2003. Characterization of glycosylation sites of the epidermal growth factor receptor. Biochemistry 42: 5478-5492. doi: 10.1021/bi027101p